Generic Name and Formulations:
Progesterone (micronized) 100mg, 200mg; caps; contains peanut oil.
Virtus Pharmaceuticals, Inc.
Indications for PROMETRIUM:
To prevent endometrial hyperplasia in postmenopausal women with an intact uterus receiving conjugated estrogens. Secondary amenorrhea.
Endometrial hyperplasia prevention: 200mg once daily in the PM for 12 sequential days of each 28-day cycle. Amenorrhea: 400mg once daily in the PM for 10 days.
Undiagnosed vaginal bleeding. Breast or genital carcinoma. Severe liver dysfunction or disease. Missed abortion. Thrombophlebitis, thromboembolic disorders, cerebral apoplexy. Not for use as a diagnostic test for pregnancy. Peanut allergy. Pregnancy (Cat.B).
Conditions that may be aggravated by fluid retention. Renal or hepatic dysfunction. Depression. Discontinue if thrombotic disorders, papilledema, or retinal vascular lesions occur. Do initial and annual physical exam (include BP, PAP smear, mammogram). Discontinue pending exam if visual disturbances or migraine occurs. Monitor diabetics. Nursing mothers: not recommended.
Dizziness, mastodynia, headache, abdominal pain/bloating, fatigue, musculoskeletal pain, emotional lability, GI upset, vaginal discharge.
Neurology Advisor Articles
- FDA Approves Aimovig for Migraine Prevention
- Prediction Algorithm Stratifies ICH Patients at Risk for Hematoma Expansion
- Sports-Related Concussion Outcomes Predicted With Serum Neurofilament Light
- FDA: Lamotrigine Linked to Potentially Life-Threatening Adverse Reaction
- Psychological Therapies May Help Older Adults With Chronic Pain
- Amyloid Positivity Increases Risk for Cognitive Impairment in Dementia-Free Patients
- Valproic Acid-Related Adverse Fetal Outcomes May Be Linked to Placental Effects
- Risk of Dementia Up for Older Adults With Lowest Wealth
- Language Used in Medical Record Can Affect Patient Care
- Mortality in Alzheimer Disease Not Strongly Associated With Antipsychotics